Webinar: Introducing New HIV Prevention Products: The Dapivirine Ring and Injectable Cabotegravir for PrEP

We're now on Instagram! Follow us @NIMHgov NEWS AND EVENTS Introducing New HIV Prevention Products: The Dapivirine Ring and Injectable Cabotegravir for PrEP Date/Time: July 20, 2022, 10:00–11:00 a.m. ET Location: Virtual  Register for This Webinar In 2021, the U.S. Agency for International Development (USAID) launched Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC), a new $85 million program funded by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) to help women around the world protect themselves from HIV. The National Institute of Mental Health (NIMH) is conducting a webinar about new HIV Pre-Exposure Prophylaxis (PrEP) product introduction planning in Africa, including an overview of the CATALYST implementation study exploring PrEP choice.

NIMH Science News Questions? Contact NIMH! Director's Messages SUBSCRIBER SERVICES: Manage Preferences  |  Unsubscribe  |  Help

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Mental Health · 6001 Executive Boulevard · Bethesda, MD 20892-9663 · 1-866-615-6464